Public Archive · PDF Reports
Investor Research Reports
Downloadable in-depth research reports. Each includes signal scoring, framing analysis, and the full PDF for offline use.
Latest report
$PJT202567 · Interesting research candidate
PJT Partners: 9.9x EV/EBITDA and 6.7x EV/FCF Price a Recovery Despite -8.9% FCF GrowthAll reports
$SEIC202562 · Mixed but researchable candidate
SEI Investments Company: 10.3x EV/EBITDA with 28.9% EPS Growth Tests the Steady-Compounder Narrative$RRR202564 · Mixed but researchable candidate
Red Rock Resorts (RRR): 4.5x EV/EBITDA and 6.0x EV/FCF Price in Normalization Despite 15.8% FCF Growth$PRDO202550 · Low priority candidate
Perdoceo (PRDO): EV/EBITDA 5.4x and EV/FCF 6.5x Despite 38.0% FCF Growth$CRCT202563 · Mixed but researchable candidate
Cricut (CRCT): 6.6x EV/EBITDA and 5.2x EV/FCF Price an Ex-Growth Hardware Story Despite 17.3% ROIC and 14.6% FCF Yield$IDCC202562 · Mixed but researchable candidate
InterDigital (IDCC): 13.1x EV/EBITDA and 12.0x EV/FCF on 8.1% FCF Yield Amid -4.0% Revenue Contraction$EXEL202567 · Interesting research candidate
Exelixis (EXEL): 13.4x EV/EBITDA and 14.6x EV/FCF Price a Mature Franchise Despite 35.0% ROIC and 33.2% FCF Growth$ADMA202549 · Low priority candidate
ADMA Biologics: 9.4x EV/EBITDA with 18.5x EV/FCF as Cash Conversion Volatility Offsets 27.8% ROIC$HRMY202566 · Mixed but researchable candidate
Harmony Biosciences (HRMY): EV/EBITDA 7.1x and EV/FCF 4.8x Price Durability Risk into a 21.5% Growth, 16.8% FCF Yield Profile$BSM202558 · Mixed but researchable candidate
Black Stone Minerals (BSM): EV/EBITDA 6.5x and EV/FCF 13.9x Reflect High-ROIC Yield Profile Facing FCF Contraction$HIG202565 · Mixed but researchable candidate
The Hartford (HIG): 7.1x EV/EBITDA and 6.8x EV/FCF Pricing a High-ROE Insurer as a Peak-Cycle Financial$OPFI202565 · Mixed but researchable candidate
OppFi (OPFI): 5.4x EV/EBITDA and 3.1x EV/FCF Against 149.0% ROIC and 23.0% FCF Growth$NRDS202565 · Mixed but researchable candidate
NerdWallet (NRDS): EV/EBITDA 4.0x and EV/FCF 4.2x Price in Cyclicality Despite 21.7% Revenue Growth and 83.0% FCF Growth$HRTG202566 · Mixed but researchable candidate
Heritage Insurance (HRTG): 0.9x EV/EBITDA and 1.3x EV/FCF Against 32.5% ROIC and 120.8% FCF Growth$THG202566 · Mixed but researchable candidate
Data Insufficient – Required Financial Metrics Not Provided$DECK202666 · Mixed but researchable candidate
Insufficient Data to Construct Institutional Thesis$HCI202568 · Interesting research candidate
HCI – High-Return Cash Generator Trading at Deep Value Multiples$DLO202568 · Interesting research candidate
DLO — High-Return Compounder Priced for Sustained Cash Conversion$DLO202557 · Mixed but researchable candidate
DLO — High-Return Growth Trading at Cash-Flow Compression Multiples$DLO202557 · Mixed but researchable candidate
dLocal (DLO): High Returns and Cash Inflection vs. Cyclical Volatility Debate$DLO202558 · Mixed but researchable candidate
DLO: High Cash Conversion and ROIC Support Mid-Teens Multiples, but Sustainability of 861.1% FCF Growth Is the Core Debate$DLO202558 · Mixed but researchable candidate
DLO: High-Return, High-Cash Conversion Business Trading Below Historical Multiples
Get research papers by email
In-depth research reports delivered to your inbox when published. Each edition gives you:
- The company ticker, fiscal year, and our proprietary signal score
- A concise summary of key findings — fundamentals, valuation, competitive positioning, and narrative framing
- Verification checklist and credibility notes for key claims
- Direct link to the full report and PDF download
These reports are built to support your independent research process with structured, high-quality insights. No investment advice — just clear, actionable context to help you evaluate opportunities more effectively. Available to all SignalShield users.
SignalShield research reports are for informational and research support only. They do not constitute investment advice, financial advice, or buy/sell/hold recommendations. Past performance is not indicative of future results.